Corcept Therapeutics (CORT) Shares Repurchased: 2018-2025
Historic Shares Repurchased for Corcept Therapeutics (CORT) over the last 3 years, with Sep 2025 value amounting to $42.5 million.
- Corcept Therapeutics' Shares Repurchased rose 262.63% to $42.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $184.6 million, marking a year-over-year increase of 37.09%. This contributed to the annual value of $15.7 million for FY2024, which is N/A change from last year.
- As of Q3 2025, Corcept Therapeutics' Shares Repurchased stood at $42.5 million, which was down 58.78% from $103.0 million recorded in Q2 2025.
- Over the past 5 years, Corcept Therapeutics' Shares Repurchased peaked at $119.0 million during Q4 2021, and registered a low of $476,000 during Q1 2024.
- Over the past 2 years, Corcept Therapeutics' median Shares Repurchased value was $19.6 million (recorded in 2024), while the average stood at $31.4 million.
- Data for Corcept Therapeutics' Shares Repurchased shows a peak YoY skyrocketed of 12,096.73% (in 2021) over the last 5 years.
- Corcept Therapeutics' Shares Repurchased (Quarterly) stood at $119.0 million in 2021, then reached $11.7 million in 2024, then spiked by 262.63% to $42.5 million in 2025.
- Its last three reported values are $42.5 million in Q3 2025, $103.0 million for Q2 2025, and $27.4 million during Q1 2025.